These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4539570)

  • 21. Reduction of platelet activity in patients with prosthetic heart valves.
    Bran M; Capel P; Messin R
    Rev Med Brux; 1980 Feb; 1(2):71-5. PubMed ID: 7403713
    [No Abstract]   [Full Text] [Related]  

  • 22. Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
    Stefanidis A; Skafidas D; Papasteriadis E
    Eur Heart J; 2007 Oct; 28(20):2552-3; author reply 2553-4. PubMed ID: 17823214
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of systemic thromboembolic accidents in patients with artificial valve prostheses. Prospective study of an antivitamins K-dipyridamole combination].
    Starkman C; Estampes B; Vernant P; Acar J
    Arch Mal Coeur Vaiss; 1982 Jan; 75(1):85-8. PubMed ID: 6803719
    [No Abstract]   [Full Text] [Related]  

  • 24. [Summary: Drugs affecting platelet behaviour; experimental and clinical data (author's transl)].
    Bouvier CA
    Ther Umsch; 1974 Feb; 31(2):84-8. PubMed ID: 4612856
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
    Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
    J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
    Delahaye JP; Milon H; Ffrench P; Philippe-Bert J; Malquarti V; Saradarian W
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):205-11. PubMed ID: 3893303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Should all prosthetic valve patients be treated by platelet inhibitors?].
    Lévy G; Bordes F; Mariottini P; François G
    Nouv Presse Med; 1976 Jan; 5(5):251-4. PubMed ID: 1264682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboembolism--a continuing challenge.
    Weiss HJ
    N Engl J Med; 1970 Dec; 283(24):1341-2. PubMed ID: 5478456
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombosis and thromboembolism in patients with a Björk-Shiley prosthesis].
    Hricák V; Kovácik M; Fridrich V
    Vnitr Lek; 1989 Apr; 35(4):340-3. PubMed ID: 2741353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of thrombosis and thromboembolism after mitral valve bioprosthesis].
    Malinovskiĭ NN; Konstantinov BA; Cherepenin LP; Dzemeshkevich SL; Ivanov AS
    Khirurgiia (Mosk); 1982 Nov; (11):64-8. PubMed ID: 7176405
    [No Abstract]   [Full Text] [Related]  

  • 32. [Thromboembolism and antithrombogenic therapy after prosthetic valve replacement].
    Saitoh H; Matsumoto H; Yagyu K; Miyawaki F; Ide H; Furuse A
    Kyobu Geka; 1988 Feb; 41(2):97-102. PubMed ID: 3361716
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
    Boda Z; Voith L; Udvardy M; Hársfalvi J; Pfliegler G; Tornai I
    Orv Hetil; 1987 Feb; 128(5):239-42. PubMed ID: 3547248
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulation after heart valve bioprosthesis].
    Hamm CW
    Dtsch Med Wochenschr; 1991 Mar; 116(13):514. PubMed ID: 2007385
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 36. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D
    Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract]   [Full Text] [Related]  

  • 37. Can early thromboembolic complications after valve replacement be avoided?
    Kure HH; Schüller H; Thulin L; Olin C
    Z Kardiol; 1986; 75 Suppl 2():302-4. PubMed ID: 3727707
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical use of anti-aggregative agents].
    Bounameaux Y
    Bull Schweiz Akad Med Wiss; 1973 Nov; 29(4):223-34. PubMed ID: 4771351
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelet survival in patients with homograft and prosthetic heart valves. Correlation with incidence of thromboembolism.
    Manohitharajah SM; Rahman AN; Donnelly RJ; Deverall PB; Watson DA
    Thorax; 1974 Nov; 29(6):639-42. PubMed ID: 4450175
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.